Back to search

Corryn Biotechnologies Ltd

13184878

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

BAY TECHNOLOGY CENTRE CENTRAL AVENUE, PORT TALBOT, SA12 7AX
Incorporated 08/02/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology
72190
Other research and experimental development on natural sciences and engineering

Officers

Dr Luke David Burke

director · Since 08/02/2021

COMPANY DIRECTOR

BRITISH · WALES · Age 37

Dr Fabio Zomer Volpato

director · Since 01/06/2023

BUSINESS EXECUTIVE

BRAZILIAN,ITALIAN · UNITED STATES · Age 43

Persons with Significant Control

Dr Luke David Burke

25–50% shares
25–50% votes
Appoint directors

British · Wales · Age 37

Bay Technology Centre, Central Avenue, Port Talbot, SA12 7AX

Notified 08/02/2021

Dr Fabio Zomer Volpato

25–50% shares
25–50% votes
Appoint directors

Italian,Brazilian · United States · Age 43

Bay Technology Centre, Central Avenue, Port Talbot, SA12 7AX

Notified 31/03/2023

CompanyRankvs 470+ SIC 72110 peers
73

Financial strength84th percentile among SIC peers · 21/25
Employees82th percentile among SIC peers · 12/15
LiquidityCurrent ratio 54.37× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
470Corryn Biotechnologies Ltd
73
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2025

Net Worth

£218k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£64k

Working capital

Current Assets

£64k

Current Liabilities

£1k

Fixed Assets

£155k

4avg. employees-1

Balance Sheet

Assets less current liabilities£219k
Signed by 13184878 2025-03-01 2025-09-30 13184878 2025-09-30 13184878 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-Prepared with Digita Accounts Production Advanced

EstimatesDerived

YearCurrent RatioImplied Profit
202554.37-£40k
202516.78+£246k
20241.33-£235
20233.80+£10k
20221.00—

Derived from filed accounts. Not audited figures.